Evidence map›Paper›PMID 25875299›Full record

ArticleEndocrinology2015

Relative Importance of the Arcuate and Anteroventral Periventricular Kisspeptin Neurons in Control of Puberty and Reproductive Function in Female Rats.

M H Hu, X F Li, B McCausland, S Y Li, R Gresham, J S Kinsey-Jones, J V Gardiner, A H Sam, S R Bloom, L Poston and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Endocrinology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
12.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 77 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. In vivo imaging of the GnRH pulse generator reveals a temporal order of neuronal activation and synchronization during each pulse.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  16. Review
  17. Optogenetic stimulation of Kiss1Frontiers in endocrinology · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

M H HuDivision of Women's Health (M.H.H., X.F.L., B.M., S.Y.L., R.G., L.P., K.T.O.), Faculty of Life Sciences and Medicine, King's College London, Guy's Campus, London SE1 1UL, United Kingdom; Section of Investigative Medicine (J.S.K.-J., J.V.G., A.H.S., S.R.B., K.G.M.), Division of Diabetes, Endocrinology, and Metabolism, Imperial College London, London W12 0NN, United Kingdom; and Henry Wellcome Laboratory for Integrative Neuroscience and Endocrinology (S.L.L.), University of Bristol, Bristol BS13NY, United Kingdom.
X F LiDivision of Women's Health (M.H.H., X.F.L., B.M., S.Y.L., R.G., L.P., K.T.O.), Faculty of Life Sciences and Medicine, King's College London, Guy's Campus, London SE1 1UL, United Kingdom; Section of Investigative Medicine (J.S.K.-J., J.V.G., A.H.S., S.R.B., K.G.M.), Division of Diabetes, Endocrinology, and Metabolism, Imperial College London, London W12 0NN, United Kingdom; and Henry Wellcome Laboratory for Integrative Neuroscience and Endocrinology (S.L.L.), University of Bristol, Bristol BS13NY, United Kingdom.
B McCauslandDivision of Women's Health (M.H.H., X.F.L., B.M., S.Y.L., R.G., L.P., K.T.O.), Faculty of Life Sciences and Medicine, King's College London, Guy's Campus, London SE1 1UL, United Kingdom; Section of Investigative Medicine (J.S.K.-J., J.V.G., A.H.S., S.R.B., K.G.M.), Division of Diabetes, Endocrinology, and Metabolism, Imperial College London, London W12 0NN, United Kingdom; and Henry Wellcome Laboratory for Integrative Neuroscience and Endocrinology (S.L.L.), University of Bristol, Bristol BS13NY, United Kingdom.
S Y LiDivision of Women's Health (M.H.H., X.F.L., B.M., S.Y.L., R.G., L.P., K.T.O.), Faculty of Life Sciences and Medicine, King's College London, Guy's Campus, London SE1 1UL, United Kingdom; Section of Investigative Medicine (J.S.K.-J., J.V.G., A.H.S., S.R.B., K.G.M.), Division of Diabetes, Endocrinology, and Metabolism, Imperial College London, London W12 0NN, United Kingdom; and Henry Wellcome Laboratory for Integrative Neuroscience and Endocrinology (S.L.L.), University of Bristol, Bristol BS13NY, United Kingdom.
R GreshamDivision of Women's Health (M.H.H., X.F.L., B.M., S.Y.L., R.G., L.P., K.T.O.), Faculty of Life Sciences and Medicine, King's College London, Guy's Campus, London SE1 1UL, United Kingdom; Section of Investigative Medicine (J.S.K.-J., J.V.G., A.H.S., S.R.B., K.G.M.), Division of Diabetes, Endocrinology, and Metabolism, Imperial College London, London W12 0NN, United Kingdom; and Henry Wellcome Laboratory for Integrative Neuroscience and Endocrinology (S.L.L.), University of Bristol, Bristol BS13NY, United Kingdom.
J S Kinsey-JonesDivision of Women's Health (M.H.H., X.F.L., B.M., S.Y.L., R.G., L.P., K.T.O.), Faculty of Life Sciences and Medicine, King's College London, Guy's Campus, London SE1 1UL, United Kingdom; Section of Investigative Medicine (J.S.K.-J., J.V.G., A.H.S., S.R.B., K.G.M.), Division of Diabetes, Endocrinology, and Metabolism, Imperial College London, London W12 0NN, United Kingdom; and Henry Wellcome Laboratory for Integrative Neuroscience and Endocrinology (S.L.L.), University of Bristol, Bristol BS13NY, United Kingdom.
J V GardinerDivision of Women's Health (M.H.H., X.F.L., B.M., S.Y.L., R.G., L.P., K.T.O.), Faculty of Life Sciences and Medicine, King's College London, Guy's Campus, London SE1 1UL, United Kingdom; Section of Investigative Medicine (J.S.K.-J., J.V.G., A.H.S., S.R.B., K.G.M.), Division of Diabetes, Endocrinology, and Metabolism, Imperial College London, London W12 0NN, United Kingdom; and Henry Wellcome Laboratory for Integrative Neuroscience and Endocrinology (S.L.L.), University of Bristol, Bristol BS13NY, United Kingdom.
A H SamDivision of Women's Health (M.H.H., X.F.L., B.M., S.Y.L., R.G., L.P., K.T.O.), Faculty of Life Sciences and Medicine, King's College London, Guy's Campus, London SE1 1UL, United Kingdom; Section of Investigative Medicine (J.S.K.-J., J.V.G., A.H.S., S.R.B., K.G.M.), Division of Diabetes, Endocrinology, and Metabolism, Imperial College London, London W12 0NN, United Kingdom; and Henry Wellcome Laboratory for Integrative Neuroscience and Endocrinology (S.L.L.), University of Bristol, Bristol BS13NY, United Kingdom.
S R BloomDivision of Women's Health (M.H.H., X.F.L., B.M., S.Y.L., R.G., L.P., K.T.O.), Faculty of Life Sciences and Medicine, King's College London, Guy's Campus, London SE1 1UL, United Kingdom; Section of Investigative Medicine (J.S.K.-J., J.V.G., A.H.S., S.R.B., K.G.M.), Division of Diabetes, Endocrinology, and Metabolism, Imperial College London, London W12 0NN, United Kingdom; and Henry Wellcome Laboratory for Integrative Neuroscience and Endocrinology (S.L.L.), University of Bristol, Bristol BS13NY, United Kingdom.
L PostonDivision of Women's Health (M.H.H., X.F.L., B.M., S.Y.L., R.G., L.P., K.T.O.), Faculty of Life Sciences and Medicine, King's College London, Guy's Campus, London SE1 1UL, United Kingdom; Section of Investigative Medicine (J.S.K.-J., J.V.G., A.H.S., S.R.B., K.G.M.), Division of Diabetes, Endocrinology, and Metabolism, Imperial College London, London W12 0NN, United Kingdom; and Henry Wellcome Laboratory for Integrative Neuroscience and Endocrinology (S.L.L.), University of Bristol, Bristol BS13NY, United Kingdom.
S L LightmanDivision of Women's Health (M.H.H., X.F.L., B.M., S.Y.L., R.G., L.P., K.T.O.), Faculty of Life Sciences and Medicine, King's College London, Guy's Campus, London SE1 1UL, United Kingdom; Section of Investigative Medicine (J.S.K.-J., J.V.G., A.H.S., S.R.B., K.G.M.), Division of Diabetes, Endocrinology, and Metabolism, Imperial College London, London W12 0NN, United Kingdom; and Henry Wellcome Laboratory for Integrative Neuroscience and Endocrinology (S.L.L.), University of Bristol, Bristol BS13NY, United Kingdom.
K G MurphyDivision of Women's Health (M.H.H., X.F.L., B.M., S.Y.L., R.G., L.P., K.T.O.), Faculty of Life Sciences and Medicine, King's College London, Guy's Campus, London SE1 1UL, United Kingdom; Section of Investigative Medicine (J.S.K.-J., J.V.G., A.H.S., S.R.B., K.G.M.), Division of Diabetes, Endocrinology, and Metabolism, Imperial College London, London W12 0NN, United Kingdom; and Henry Wellcome Laboratory for Integrative Neuroscience and Endocrinology (S.L.L.), University of Bristol, Bristol BS13NY, United Kingdom.
K T O'ByrneDivision of Women's Health (M.H.H., X.F.L., B.M., S.Y.L., R.G., L.P., K.T.O.), Faculty of Life Sciences and Medicine, King's College London, Guy's Campus, London SE1 1UL, United Kingdom; Section of Investigative Medicine (J.S.K.-J., J.V.G., A.H.S., S.R.B., K.G.M.), Division of Diabetes, Endocrinology, and Metabolism, Imperial College London, London W12 0NN, United Kingdom; and Henry Wellcome Laboratory for Integrative Neuroscience and Endocrinology (S.L.L.), University of Bristol, Bristol BS13NY, United Kingdom.
King's College London · GBImperial College London · GBUniversity of Bristol · GB

Funding

Biotechnology and Biological Sciences Research Council BB/E52708X/1Wellcome Trust
6 · The paper itself

Abstract

Kisspeptin plays a critical role in pubertal timing and reproductive function. In rodents, kisspeptin perikarya within the hypothalamic arcuate (ARC) and anteroventral periventricular (AVPV) nuclei are thought to be involved in LH pulse and surge generation, respectively. Using bilateral microinjections of recombinant adeno-associated virus encoding kisspeptin antisense into the ARC or AVPV of female rats at postnatal day 10, we investigated the relative importance of these two kisspeptin populations in the control of pubertal timing, estrous cyclicity, and LH surge and pulse generation. A 37% knockdown of kisspeptin in the AVPV resulted in a significant delay in vaginal opening and first vaginal estrous, abnormal estrous cyclicity, and reduction in the occurrence of spontaneous LH surges, although these retained normal amplitude. This AVPV knockdown had no effect on LH pulse frequency, measured after ovariectomy. A 32% reduction of kisspeptin in the ARC had no effect on the onset of puberty but resulted in abnormal estrous cyclicity and decreased LH pulse frequency. Additionally, the knockdown of kisspeptin in the ARC decreased the amplitude but not the incidence of LH surges. These results might suggest that the role of AVPV kisspeptin in the control of pubertal timing is particularly sensitive to perturbation. In accordance with our previous studies, ARC kisspeptin signaling was critical for normal pulsatile LH secretion in female rats. Despite the widely reported role of AVPV kisspeptin neurons in LH surge generation, this study suggests that both AVPV and ARC populations are essential for normal LH surges and estrous cyclicity.

Indexed as

AnimalsArcuate Nucleus of HypothalamusEstrous CycleFemaleGene Knockdown TechniquesHypothalamus, AnteriorKisspeptinsLuteinizing HormoneNeuronsPubertyRatsSexual MaturationKiss1 protein, ratKisspeptinsLuteinizing Hormone

Identifiers

PMID25875299
PMCPMC4475719
OpenAlexW2151573530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.